Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Amy L. Kiskaddon"'
Autor:
Amy L. Kiskaddon, PharmD, MBA, Neil A. Goldenberg, MD, PhD, Trent Abel, PharmD, Jamie L. Fierstein, PhD, Delia Khayat, BS, James A. Quintessenza, MD, Arabela C. Stock, MD
Publikováno v:
Critical Care Explorations, Vol 6, Iss 4, p e1078 (2024)
BACKGROUND:. Pain management is essential for postoperative surgery. Given the association of opioids with adverse outcomes, interest in the use of nonopioid analgesics, such as ketorolac, has increased. Published data on use in neonates are limited.
Externí odkaz:
https://doaj.org/article/b01fa0964e304a2abc2bd11a150d5bdf
Autor:
Amy L. Kiskaddon, PharmD, MBA, Michelle M. Smith, MD, Frankie Gilliland, DNP, CPNP, AC/PC, Megan A. Rech, PharmD, MS, FCCM, Pharmacist Avoidance or Reductions in Medical Costs in Critically and Emergently Ill Pediatrics (PHARM-PEDS) Investigators
Publikováno v:
Critical Care Explorations, Vol 5, Iss 10, p e0980 (2023)
OBJECTIVES:. To comprehensively classify interventions performed by pediatric critical care clinical pharmacists and quantify cost avoidance (CA) generated through their accepted interventions. DESIGN:. A multicenter, prospective, observational study
Externí odkaz:
https://doaj.org/article/1df8986d39304829ae1a33357ff192ae
Autor:
Amy L. Kiskaddon, Jamie Decker
Publikováno v:
Journal of Cardiovascular Electrophysiology.
Autor:
Amy L. Kiskaddon, Michael Wilsey, Ignacio Gonzalez‐Gomez, Jessica Laks, Alyssa Miles, Jennifer Carapellucci, Alfred Asante‐Korang
Publikováno v:
Pediatric Transplantation. 27
Publikováno v:
Seminars in Thrombosis and Hemostasis. 48:434-445
Venous thromboembolism (VTE) is a leading cause of morbidity and preventable harm among noncritically ill hospitalized children. Several clinical factors relevant to the noncritically ill hospitalized child significantly increase the risk of VTE incl
Autor:
Brian K. Brown, Jennifer Carapellucci, Bethany L. Wisotzkey, Amy L. Kiskaddon, Alfred Asante-Korang
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:548-553
Autor:
Bethany L. Wisotzkey, Jennifer Carapellucci, Alfred Asante-Korang, Amy L. Kiskaddon, Katherine B. Landmesser
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 46:762-766
WHAT IS KNOWN AND OBJECTIVE Epstein-Barr virus (EBV) viraemia and autoimmune cytopenias (AICs) are significant complications that occur following paediatric solid organ transplantation. A variety of treatment methods have been investigated but limite
Autor:
Frankie Gilliland, Grace Freire, Daniel Mauriello, Brian K. Brown, Joette Amundaray Miller, Amy L. Kiskaddon, Sarah J. Rockwell
Publikováno v:
Clinical Pulmonary Medicine. 27:43-47
Publikováno v:
Seminars in thrombosis and hemostasis. 47(6)
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality among hospitalized patients, including children. In recent years, it has become clear that hospitalization and critical illness bestow an increased VTE risk in pediatrics and
Autor:
Neil A. Goldenberg, Amy L. Kiskaddon, Carli Coalter, Joshua W. Branstetter, Christoph Male, Kimberly M. Grubbs, Hunter Fly, Leonardo R. Brandão, Madeleine A. King
Publikováno v:
Seminars in thrombosis and hemostasis. 47(6)
Venous thromboembolism (VTE) in children can lead to significant morbidity and mortality. Traditionally, treatment for thrombotic events in pediatric patients has been limited mainly to unfractionated heparin, low-molecular-weight heparin (LMWH), or